CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD. Funds and ETFs Chengdu Kanghua Biological Products Co., Ltd.
Equities
300841
CNE100003Y57
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.82 CNY | -0.29% |
|
+8.31% | -18.98% |
ETFs positioned on Chengdu Kanghua Biological Products Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 12 M€ | -16.71% | - | |
| 0.00% | 34 M€ | +1.51% | - |
Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine products. The Company's main products are Rabies Vaccine (human diploid cell) for Human Use, Freeze-dried and Group ACYW135 Meningococcal Polysaccharide Vaccine. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
62.82
CNY
Average target price
102
CNY
Spread / Average Target
+62.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.98% | 1.15B | |
| -4.10% | 87.17B | |
| +2.76% | 40.1B | |
| -16.98% | 31.38B | |
| +57.86% | 25.12B | |
| -16.24% | 15.59B | |
| -9.12% | 12B | |
| -42.56% | 11.8B | |
| -17.10% | 11.8B | |
| +6.89% | 8.81B |
- Stock Market
- Equities
- 300841 Stock
- Funds and ETFs Chengdu Kanghua Biological Products Co., Ltd.
